Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.43 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14548162 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL80731 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL14130407 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL80732 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL13559128 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL12449334 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL18271744 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL12521907 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL13619173 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 | |
| SCHEMBL725337 | 1.00 | TRPA1 (0.43) | TRPA1TRPM8GBA1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4723887-A1 | METHODS AND COMPOUNDS | University of Leicester (GB) | 2026-04-15 | — | — | EP | disclosed |
| WO-2024252135-A1 | METHODS AND COMPOUNDS | UNIVERSITY OF LEICESTER (GB) | 2024-12-12 | — | — | WO | disclosed |
| US-20240238216-A1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE, S.L. (ES) | 2024-07-18 | — | — | US | disclosed |
| US-20240238216-A1 | SLOW-RELEASE FORMULATION | GLYCOSCIENCE, S.L. (ES) | 2024-07-18 | — | — | US | disclosed |
| US-7396547-B2 | Antiseptic composition | CLARKE PAUL DOUGLAS | 2008-07-08 | — | — | US | disclosed |
| US-7396547-B2 | Antiseptic composition | CLARKE PAUL DOUGLAS | 2008-07-08 | — | — | US | disclosed |
| US-20070122499-A1 | ANTISEPTIC COMPOSITION | CLARKE PAUL D | 2007-05-31 | — | — | US | disclosed |
| US-20070122499-A1 | ANTISEPTIC COMPOSITION | CLARKE PAUL D | 2007-05-31 | — | — | US | disclosed |
| US-7189421-B2 | Antiseptic composition | CLARKE PAUL DOUGLAS | 2007-03-13 | — | — | US | disclosed |
| US-7189421-B2 | Antiseptic composition | CLARKE PAUL DOUGLAS | 2007-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238216-A1 | SLOW-RELEASE FORMULATION | SORD, G6PD, GMDS | TRPA1 2146/4885TRPM8 1090/4885GBA1 214/4885 |
| US-20070122499-A1 | ANTISEPTIC COMPOSITION | DPM1, CUTA, NACA | TRPA1 267/4885TRPM8 188/4885GBA1 3404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.